Biomaterial Database

Screening and treatment of infections caused by resistant enterococci. 1991

D J Herman, and D N Gerding

Department of Medicine, Veterans Affairs Medical Center, Minneapolis, Minnesota.

UI	MeSH Term	Description	Entries
D004352	Drug Resistance, Microbial	The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).	Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006094	Gram-Positive Bacteria	Bacteria which retain the crystal violet stain when treated by Gram's method.	Gram Positive Bacteria
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001424	Bacterial Infections	Infections by bacteria, general or unspecified.	Bacterial Disease,Bacterial Infection,Infection, Bacterial,Infections, Bacterial,Bacterial Diseases

Related Publications

D J Herman, and D N Gerding

Treatment of infections caused by highly resistant enterococci.

May 1997, International journal of antimicrobial agents,

D J Herman, and D N Gerding

[Treatment options for serious infections caused by vancomycin-resistant enterococci].

January 2015, Deutsche medizinische Wochenschrift (1946),

D J Herman, and D N Gerding

Endovascular infections caused by enterococci highly resistant to ampicillin.

December 1991, Southern medical journal,

D J Herman, and D N Gerding

Linezolid for the Treatment of Urinary Tract Infections Caused by Vancomycin-Resistant Enterococci.

October 2021, Pharmacy (Basel, Switzerland),

D J Herman, and D N Gerding

Antimicrobial agents for treatment of serious infections caused by resistant Staphylococcus aureus and enterococci.

December 2005, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,

D J Herman, and D N Gerding

Economic burden of nosocomial infections caused by vancomycin-resistant enterococci.

January 2018, Antimicrobial resistance and infection control,

D J Herman, and D N Gerding

Costs of treating infections caused by methicillin-resistant staphylococci and vancomycin-resistant enterococci.

September 1999, The Journal of antimicrobial chemotherapy,

D J Herman, and D N Gerding

Sitafloxacin in the treatment of patients with infections caused by vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus.

October 2000, The Journal of antimicrobial chemotherapy,

D J Herman, and D N Gerding

[Treatment of endocarditis and other severe infections caused by enterococci].

March 1996, Enfermedades infecciosas y microbiologia clinica,